期刊文献+

PEP-1-SODl融合蛋白的制备、表达及纯化 被引量:4

PEP-1-SOD1 fusion protein:preparation, expression and purification
下载PDF
导出
摘要 目的:构建原核表达载体pQE30-PEP-1-SOD1,并进行PEP-1-SOD1融合蛋白表达和纯化。方法载体质粒pQE-30及模板质粒pUC57-PEP-1-SOD1分别进行酶切后,构建原核表达载体pQE30-PEP-1-SOD1载体。经测序证实构建成功后,转化JM109,表达PEP-1-SOD1融合蛋白,并进行鉴定。结果 SDS-PAGE电泳分析表明,位于相对分子质量约25×10^3处出现PEP-1-SOD1的目标表达条带;目的蛋白以天然的可溶性的形式存在。结论已成功制备出PEP-1-SOD1融合蛋白。 Objective To establish a prokaryotic expression vector pQE 30-PEP-1-SOD1 and express and purify PEP-1-SOD1 fusion protein .Methods The vector pQE30-PEP-1-SOD1 was established using a plasmid pQE -30 and a template plasmid pUC57-PEP-1-SOD1 through enzymatic digestion .The recombinant plasmid was then se-quenced before transformed into JM109 for expression of PEP -1-SOD1 fusion protein.The resultant products were i-dentified by SDS-PAPG electrophoresis.Results According to SDS-PAGE analysis, the target protein was present in a soluble form with about 25×10 3 molecular weight .Conclusion The fusion protein PEP -1-SOD1 is successfully prepared.
出处 《徐州医学院学报》 CAS 2015年第2期105-108,共4页 Acta Academiae Medicinae Xuzhou
基金 常州市卫生局重大科研项目(ZD201212)
关键词 锌-超氧化物歧化酶 原核表达 PEP-1肽 融合蛋白 Cu,Zn-superoxide dismutase prokaryotic expression PEP-1 peptide fusion protein
  • 相关文献

参考文献6

  • 1Brooks H, Lebleu B, Vives E. Tat peptide - mediated cellular de- livery : back to basics [ J ]. Adv Drug Deliv Rev, 2005,57 (4) : 559 - 577.
  • 2Yamakura F, Kawasaki H. Post - translational modifications of su- peroxide dismutase [ J]. Biochim Biophys Acta, 2010,1804 ( 2 ) : 318 -325.
  • 3孟丽华,薛荣亮.蛋白质转导超氧物歧化酶融合蛋白在脑缺血/缺氧损伤中的研究进展[J].国际麻醉学与复苏杂志,2014,35(2):188-192. 被引量:6
  • 4Arslantas A. Development of Functional Models for a SOD [ J ]. Met Based Drugs, 2002,9( 1 -2) :9 -18.
  • 5Davis AS, Zhao H, Sun GH,et al. Gene therapy using SOD1 pro- tects striatal neurons from experimental stroke [ J ]. Neurosci Lett, 2007,411(1) :32 -36.
  • 6Morris MC, Depollier J, Mery J, et al. A peptide carrier for the delivery of biologically active proteins into mammalian cells [J].Nat Biotechnol, 2001,19(12) :1173 -1176.

二级参考文献18

  • 1Perry J J, Shin DS, Getzoff ED, et al. The structural biochemistry of the superoxide dismutases[J]. Biochim Biophys Acta, 2010, 1804 (2) : 245 -262.
  • 2Yamakura F, Kawasaki H. Post-translational modifications of superoxide dismutase[J]. Biochim Biophys Acta, 2010, 1804(2): 318-325.
  • 3Abreu IA, Cabelli DE. Superoxide dismutases-a review of the metal-associated mechanistic variations[J]. Biochim Biophys Acta, 2010, 1804(2): 263-274.
  • 4Matsui H, Tomizawa K, Lu YF, et al. Protein therapy: in vivo protein transduction by polyarginine (llR) PTD and subcellular targeting delivery [J]. Curt Protein Pept Sci, 2003, 4 (2): 151-157.
  • 5Ho A, Schwarze SR, Mermelstein S J, et al. Synthetic protein transduction domains: enhanced transduetion potential in vitro and in vivo[J]. Cancer Res, 2001, 61(2): 474-477.
  • 6Yu D, Jin C, Ramaehandran M, et al. Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures [J]. PLoS One, 2013, 8(1): e54952.
  • 7Asoh S, Ohta S. PTD-mediated delivery of anti-cell death proteins/ peptides and therapeutic enzymes [J]. Adv Drug Deliv Rev, 2008, 60(4-5): 499-516.
  • 8Kwon HY, Eum WS, Jang HW, et al. Transduction of Cu, Zn- superoxide dismutase mediated by an HIV-ltat protein basic domaininto mammalian cells[J]. FEBS Lett, 2000, 485(2-3): 163-167.
  • 9Eum WS, Choung IS, Li MZ, et al. HIV-1 TAT-mediated protein transduction of Cu, Zn-superoxide dismutase into pancreatic cells in vitro and in vivo[J]. Free Radic Biol Med, 2004, 37(3): 339-349.
  • 10Kilic E, Kilic U, Hermann DM. TAT fusion proteins against ischemic stroke: current status and future perspectives[J ]. Front Biosc, 2006, 11: 1716-17121.

共引文献5

同被引文献60

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部